"10.1371_journal.pone.0090978","plos one","2014-03-13T00:00:00Z","√Ålvaro H Borges; Jemma L O‚ÄôConnor; Andrew N Phillips; Jason V Baker; Michael J Vjecha; Marcelo H Losso; Hartwig Klinker; Gustavo Lopardo; Ian Williams; Jens D Lundgren; for the INSIGHT SMART and ESPRIT Study Groups and the SILCAAT Scientific Committee","Centre for Health & Infectious Diseases Research (CHIP), Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Research Department of Infection and Population Health, University College London, London, United Kingdom; Hennepin County Medical Center, Minneapolis, Minnesota, United States of America; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, United States of America; Veterans Affairs Medical Center, Washington, D. C., United States of America; Hospital JM Ramos Mejia, Buenos Aires, Argentina; University of W√ºrzburg Medical Center, W√ºrzburg, Germany; Fundaci√≥n Centro de Estudios Infectol√≥gicos, Buenos Aires, Argentina; Centre for Sexual Health & HIV Research, University College London, London, United Kingdom","Conceived and designed the experiments: √ÅHB JLO ANP JVB JDL. Analyzed the data: √ÅHB JLO ANP. Contributed reagents/materials/analysis tools: √ÅHB JLO ANP JVB MV MHL HK GL IW JDL. Wrote the paper: √ÅHB JLO ANP JDL. Interpreted data: √ÅHB JLO ANP JVB MV MHL HK GL IW JDL. Critically revised the manuscript: √ÅHB JLO ANP JVB MV MHL HK GL IW JDL. Approved the final manuscript: √ÅHB JLO ANP JVB MV MHL HK GL IW JDL.","JVB receives research support from Gilead Pharmaceuticals and ViiV Health Care. VC and JE are affiliated with International Drug Distribution (CTS Inc., Durham, NC). The SILCAAT trial was supported by grants from Chiron and Novartis. There are no patents, products in development or marketed products to declare. This does not alter the authors‚Äô adherence to all the PLOS ONE policies on sharing data and materials.","2014","03","√Ålvaro H Borges","√HB",11,TRUE,5,NA,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
